Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial

Authors: Christopher Farina, Michael H. Davidson, Prediman K. Shah, Charles W. Stark, Wenqi Lu, Cheerag Shirodaria, Timothy Wright, Charalambos Antoniades, Jan Nilsson, Nehal N. Mehta - Cardiovascular Research 2024 cited by 30